Evaluation of treatment of local bladder cancer with Bacille Calmette-Guérin (BCG). Is treatment follow up in the outpatient department just as good as follow up in the operating theatre?
Completed
- Conditions
- Cancer of the urinary bladder - carcinoma of the bladder - CISMalignant neoplasm of bladderCancer
- Registration Number
- ISRCTN48222814
- Lead Sponsor
- Frederiksberg Hospital (Denmark)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Patients who have had 6 weekly BCG bladder instillations as treatment of primary or secondary carcinoma in situ of the bladder.
Exclusion Criteria
Patients who do not understand Danish or who the investigators do not find able to fulfil the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method